VivArt-X Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

VivArt-X General Information

Description

Developer of a personalized regenerative healthcare service intended to help women who have undergone breast tissue removal after a cancer diagnosis. The company offers a synthetic and degradable biomaterial designed to support cell engraftment, enabling women to achieve personalized breast reconstruction and tissue regeneration.

Contact Information

Website
www.vivart-x.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Het Eeuwsel 57
  • 5612 AS Eindhoven
  • Netherlands
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
FemTech, HealthTech, Life Sciences, Oncology
Corporate Office
  • Het Eeuwsel 57
  • 5612 AS Eindhoven
  • Netherlands

VivArt-X Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VivArt-X Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 11-Aug-2026 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Seed Round 08-May-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out Completed Generating Revenue
To view VivArt-X’s complete valuation and funding history, request access »

VivArt-X Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VivArt-X Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest International Impact Investing
Borski Fund Venture Capital Minority
Brabantse Ontwikkelings Maatschappij Venture Capital Minority
Brabant Startup Fund Venture Capital Minority
Eindhoven University of Technology University Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

VivArt-X FAQs

  • When was VivArt-X founded?

    VivArt-X was founded in 2022.

  • Where is VivArt-X headquartered?

    VivArt-X is headquartered in Eindhoven, Netherlands.

  • What is the size of VivArt-X?

    VivArt-X has 9 total employees.

  • What industry is VivArt-X in?

    VivArt-X’s primary industry is Biotechnology.

  • Is VivArt-X a private or public company?

    VivArt-X is a Private company.

  • What is VivArt-X’s current revenue?

    The current revenue for VivArt-X is .

  • How much funding has VivArt-X raised over time?

    VivArt-X has raised $707K.

  • Who are VivArt-X’s investors?

    Invest International, Borski Fund, Brabantse Ontwikkelings Maatschappij, Brabant Startup Fund, and Eindhoven University of Technology are 5 of 10 investors who have invested in VivArt-X.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process